Courtagen Launches New Avantra Genetics Division

Courtagen Life Sciences, Inc., has launched Avantra Genetics. Avantra is dedicated to providing advanced genomic information for functional medicine practices. Patients suffering from functional disorders may experience symptoms such as pain, fatigue, numbness or sensations and gastrointestinal distress that can be severe, chronic or debilitating.

Tetra Bio-Pharma Starts Phase I Clinical Study of Smoked Cannabis.

Tetra Bio-Pharma (CSE: TBP) (CSE: TBP.CN), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that Health Canada has approved its Phase I clinical study of smoked cannabis.

Valens GroWorks Enters Into $1.2m Loan Repayment Agreements

 Valens GroWorks Corp. (CSE: VGW) together with its subsidiary is pleased to announce its engagement under a 5-year, renewable, Professional Services Agreement  with Arizona-based marijuana cultivation and medicinal dispensary business MKHS.

InMed's Pharmaceuticals Inc. 2017 Prospects

InMed Pharmaceuticals Inc. (CSE:IN, OTCQB:IMLFF) is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs.

Mining for Marijuana in Canada

Spirit Gold (SG.v) once an exploration stage company engaged in acquiring, exploring and evaluating mineral resource has turned their attention to Marijuana. Spirit Gold Entered Into Definitive Agreement to Acquire Northern Lights Marijuana Company.

Investing In A Different Kind Of Oil

In Canada, medical marijuana patients have the option to get their medication in dried form, as a concentrated oil or even fresh. Right now there are 38 approved licensed producers of medical marijuana of which only 22 produce oil. So why should this matter to Investors?

Rising India Inc. Enters the $6.5 Billion Cannabis Industry

Rising India Inc. (OTC: RSII) announced that the company is targeting opportunities in the cannabis industry. The company is in active negotiations to reach a Letter of Intent with business operators that are currently active in the cannabis industry.

Alliance Growers Executes Founder’s Agreement with Private LP Applicant

Tel: 778-998-5431 THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE. FORWARD LOOKING INFORMATION This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance.

Alliance Growth Corp. (CSE:AGC) Assembles Top-Teir Growing Team

Alliance Growth Corp. executives announce that the Company has executed the founders agreement with a private Health Canada Licensed Producer Applicant based in Ontario, Canada.

The next step is a $25,000 first payment for the equity investment. The agreement will include long term plantlet supply contract and an off-take agreement at wholesale cost for flower to be used for CBD oil extraction at the Cannabis Botany Centre.

GW Pharma Looks Better Than Ever to Investors

The world’s largest company involved with producing therapeutics derived from cannabis posted a fiscal first-quarter loss of $19.25 million.

GW Pharmaceuticals (NASDAQ:GWPH) said it lost $0.768 per American depository share (ADS) in its fiscal first quarter, well below analysts’ consensus estimate of $1.20. Each ADS represents 12 ordinary shares.

Invictus MD (CSE:IMH, OTC:IVITF) Aquires 150 acres to Increase Production

Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares of a late stage applicant ("OptionCo") from its current shareholders. OptionCo has built 60,000 square feet of secured perimeter for its current production facility located on 150 acres, which is expected to have production capacity of up to 6,000 kg per annum. OptionCo has already submitted plans for additional buildings on the Property including a 30,000 square foot facility.